Plain-English translation of NCT07145073 on ClinicalTrials.gov โ ยท Source last updated ยท Translation generated ยท How we translate trials
This study doesn't follow the usual testing phases โ it may be an observational study or a different type of research.
This trial is testing repetitive transcranial alternating current stimulation (rtACS) โ a non-invasive procedure that uses mild electrical currents applied to the scalp to stimulate the brain โ as a potential treatment for glaucoma. The goal is to see whether this treatment can help activate nerve cells in the eye that have been damaged by glaucoma, and improve both how the eye looks under imaging tests and how well you can see.
Glaucoma damages the nerve cells in the eye, leading to progressive vision loss that current treatments can only slow down, not reverse. This trial is exploring whether brain stimulation might help wake up these damaged cells and restore some lost vision.
You likely qualify ifโฆ
You likely don't qualify ifโฆ
If you qualify and are chosen for this study, you would come to the hospital for 10 days of treatment. Each day, you would receive the brain stimulation treatment, which involves placing electrodes on your scalp to deliver mild electrical currents โ the procedure is non-invasive and painless. Half of the participants will receive the active treatment, while the other half will receive a sham (placebo) treatment where the device is applied but no stimulation is delivered. Before, during, and after the 10 days, you will have vision tests and eye imaging to measure whether the treatment helps improve your vision.
AI-generated summary from trial data ยท Jun 3, 2026 ยท Not medical advice
Taiwan
Sponsor
National Taiwan University Hospital
Enrollment target
~188 participants
Started
January 2026
Primary completion
December 2027
Age range
18 Years and older
Last updated on clinicaltrials.gov in January 2026.
Reach out to the team running this trial. Response times vary โ some teams are faster than others.
Central contact
Chien-Chia Su
National Taiwan University Hospital
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first โ no email needed to get started.